# Evaluation of the Safety and Efficacy of SALI-10 Probiotic Lozenges

> **NCT07508839** · NA · NOT_YET_RECRUITING · sponsor: **Ostia Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Gingivitis
- Halitosis

## Interventions

- **DIETARY_SUPPLEMENT:** 3B SALI-10 Lozenge
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07508839
- **Lead sponsor:** Ostia Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-01
- **Final completion:** 2027-04
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07508839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07508839, "Evaluation of the Safety and Efficacy of SALI-10 Probiotic Lozenges". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT07508839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*